Intelligent Catheter Assembly for Prosthetic Heart Valve Delivery
Legal Citation
Summary of the Inventive Concept
A synergistic system integrating a catheter assembly with advanced technologies like AI, IoT, blockchain, and new materials to revolutionize prosthetic heart valve delivery and patient care.
Background and Problem Solved
The original patent, 'Catheter assembly,' provided a solution for delivering prosthetic heart valves. However, it had limitations in terms of real-time monitoring, data tracking, and patient outcome prediction. The new inventive concept addresses these limitations by incorporating advanced technologies to enhance the overall delivery process, improve patient safety, and provide personalized care.
Detailed Description of the Inventive Concept
The intelligent catheter assembly comprises a catheter assembly, a blockchain-based tracking module, an artificial intelligence (AI) module, a sensor array, and an IoT-enabled communication module. The blockchain-based tracking module ensures the authenticity and origin of the prosthetic heart valve, while the AI module optimizes the implantation process based on real-time imaging data. The sensor array detects and responds to changes in the patient's vital signs during the procedure, and the IoT-enabled communication module transmits real-time data to a remote monitoring station. The system also utilizes machine learning algorithms to analyze data from the catheter assembly and generate personalized risk assessment reports for predicting patient outcomes.
Novelty and Inventive Step
The new inventive concept's novelty lies in the synergistic integration of advanced technologies with the catheter assembly, providing a holistic solution for prosthetic heart valve delivery. The inventive step is the application of these technologies to enhance the delivery process, improve patient safety, and provide personalized care.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different AI algorithms, various sensor arrays, or alternative communication protocols. Variations may also include integrating the system with other medical devices or using different materials for the catheter assembly.
Potential Commercial Applications and Market
The intelligent catheter assembly has significant commercial potential in the medical device industry, particularly in the field of cardiovascular surgery. The system's ability to provide real-time monitoring, personalized care, and improved patient outcomes makes it an attractive solution for hospitals, medical centers, and healthcare providers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/2436 |
| A | A61 | A61F2/2433 |
| A | A61 | A61F2/2439 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically endovascular catheter systems for prosthetic heart valve delivery, requiring expertise in mechanical design, biomedical engineering, and interventional medical technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, 3-5 years experience in catheter design, familiar with minimally invasive cardiovascular interventional techniques, advanced materials, and emerging medical technology integration strategies
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies like AI, blockchain, and IoT into existing catheter assembly designs represents a predictable evolution of medical device engineering. The fundamental mechanical structure of the catheter assembly remains consistent with the source patent, while adding computational and tracking capabilities that are well-established in contemporary medical technology development. These technological enhancements represent incremental improvements that would be obvious to a skilled practitioner seeking to enhance device functionality and patient safety.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,416 |
|---|---|
| Title | Catheter assembly |
| Assignee(s) | EDWARDS LIFESCIENCES CORPORATION |